FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

James Mulshine

Research Profile

Disorders

Anatomy

Chemicals & Drugs

Procedures

Co-author Network

Publications

TOP 3
James L Mulshine; Frank G Ondrey
Not significant but important.
Michael T Jaklitsch; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; John H M Austin; John K Field; Francine L Jacobson; Scott J Swanson; William D Travis; David J Sugarbaker
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; David J Sugarbaker; Scott J Swanson; William D Travis; Michael T Jaklitsch
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of James Mulshine (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2013: James L Mulshine; Frank G Ondrey
Not significant but important.
Cancer prevention research (Philadelphia, Pa.) 2013;6(5):371-4.
2012: Michael T Jaklitsch; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; John H M Austin; John K Field; Francine L Jacobson; Scott J Swanson; William D Travis; David J Sugarbaker
The American Association for Thoracic Surgery guidelines for lung cancer screening using low-dose computed tomography scans for lung cancer survivors and other high-risk groups.
The Journal of thoracic and cardiovascular surgery 2012;144(1):33-8.
2012: Francine L Jacobson; John H M Austin; John K Field; James R Jett; Shaf Keshavjee; Heber MacMahon; James L Mulshine; Reginald F Munden; Ravi Salgia; Gary M Strauss; David J Sugarbaker; Scott J Swanson; William D Travis; Michael T Jaklitsch
Development of The American Association for Thoracic Surgery guidelines for low-dose computed tomography scans to screen for lung cancer in North America: recommendations of The American Association for Thoracic Surgery Task Force for Lung Cancer Screening and Surveillance.
The Journal of thoracic and cardiovascular surgery 2012;144(1):25-32.
2012: Bruce Pyenson; Marcia S Sander; Yiding Jiang; Howard Kahn; James L Mulshine
An actuarial analysis shows that offering lung cancer screening as an insurance benefit would save lives at relatively low cost.
Health affairs (Project Hope) 2012;31(4):770-9.
2011: James L Mulshine; Rob J van Klaveren
Lung cancer screening: what is the benefit and what do we do about it?
Lung cancer (Amsterdam, Netherlands) 2011;71(3):247-8.
2010: Jordi Tauler; Enrique Zudaire; Huaitian Liu; Joanna Shih; James L Mulshine
hnRNP A2/B1 modulates epithelial-mesenchymal transition in lung cancer cell lines.
Cancer research 2010;70(18):7137-47.
2010: James L Mulshine; Thomas Baer; Ricardo S Avila
Introduction: Imaging in diagnosis and treatment of lung cancer.
Optics express 2010;18(14):15242-3.
2010: Ricardo S Avila; Javier J Zulueta; Nawar M Shara; Kenneth Jansen; Giulia Veronesi; Hong Wang; James L Mulshine
A quantitative method for estimating individual lung cancer risk.
Academic radiology 2010;17(7):830-40.
2010: Sara W Goldberg; James L Mulshine; Dale Hagstrom; Bruce Pyenson
An actuarial approach to comparing early stage and late stage lung cancer mortality and survival.
Population health management 2010;13(1):33-46.
2010: Geraldine Chow; Jordi Tauler; James L Mulshine
Cytokines and growth factors stimulate hyaluronan production: role of hyaluronan in epithelial to mesenchymal-like transition in non-small cell lung cancer.
Journal of biomedicine & biotechnology 2010;2010():485468.
2010: Andrew J Buckler; James L Mulshine; Ronald Gottlieb; Binsheng Zhao; P David Mozley; Lawrence Schwartz
The use of volumetric CT as an imaging biomarker in lung cancer.
Academic radiology 2010;17(1):100-6.
2009: James L Mulshine; David M Jablons
Volume CT for diagnosis of nodules found in lung-cancer screening.
The New England journal of medicine 2009;361(23):2281-2.
2009: Jordi Tauler; James L Mulshine
Lung cancer and inflammation: interaction of chemokines and hnRNPs.
Current opinion in pharmacology 2009;9(4):384-8.
2009: James L Mulshine; Rick Avila; David Yankelevitz; Thomas Baer
Use of high-resolution CT imaging data in lung cancer drug development: measuring progress.
Oncology (Williston Park, N.Y.) 2009;23(5):434-8.
2008: Giulia Veronesi; Massimo Bellomi; James L Mulshine; Giuseppe Pelosi; Paolo Scanagatta; Giovanni Paganelli; Patrick Maisonneuve; Lorenzo Preda; Francesco Leo; Raffaella Bertolotti; Piergiorgio Solli; Lorenzo Spaggiari
Lung cancer screening with low-dose computed tomography: a non-invasive diagnostic protocol for baseline lung nodules.
Lung cancer (Amsterdam, Netherlands) 2008;61(3):340-9.
2008: James L Mulshine
Commentary: lung cancer screening--progress or peril.
The oncologist 2008;13(4):435-8.
2008: Anatoly L Mayburd; Inna Golovchikova; James L Mulshine
Successful anti-cancer drug targets able to pass FDA review demonstrate the identifiable signature distinct from the signatures of random genes and initially proposed targets.
Bioinformatics (Oxford, England) 2008;24(3):389-95.
2008: Jordi Tauler; James L Mulshine
Combination Therapy of PPARgamma Ligands and Inhibitors of Arachidonic Acid in Lung Cancer.
PPAR research 2008;2008():750238.
2007: Thomas Baer; James L Mulshine; Joshua J Jacobs
Biomedical imaging archive network.
Skeletal radiology 2007;36(9):799-801.
2006: James L Mulshine
Early lung cancer detection: approaching the 'tipping point'?
Oncology (Williston Park, N.Y.) 2006;20(12):1632.
2006: James L Mulshine; Ricardo S Avila; Fred R Hirsch; David Yankelevitz
Developing CT image-processing tools to accelerate progress in lung cancer drug development.
Oncology (Williston Park, N.Y.) 2006;20(12):1606, 1608-10, 1614 passim.
2006: Apar Kishor Ganti; James L Mulshine
Lung cancer screening.
The oncologist 2006;11(5):481-7.
2006: Anatoly L Mayburd; Alfredo Martlínez; Daniel Sackett; Huaitian Liu; Joanna Shih; Jordi Tauler; Ingalill Avis; James L Mulshine
Ingenuity network-assisted transcription profiling: Identification of a new pharmacologic mechanism for MK886.
Clinical cancer research : an official journal of the American Association for Cancer Research 2006;12(6):1820-7.
2005: James L Mulshine
Current issues in lung cancer screening.
Oncology (Williston Park, N.Y.) 2005;19(13):1724-30; discussion 1730-1.
2005: James L Mulshine
Chemoprevention of head and neck cancer.
Clinical advances in hematology & oncology : H&O 2005;3(10):763-5.
2005: James L Mulshine
Clinical issues in the management of early lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):4993s-4998s.
2005: Thomas J Lynch; Jeffrey A. Bogart; Walter Curran; Malcolm M DeCamp; David R Gandara; Glenwood Goss; Claudia I Henschke; James R Jett; Bruce E Johnson; Karen L Kelly; Thierry Le Chevalier; James L Mulshine; Giorgio V Scagliotti; Joan H Schiller; Alice Shaw; Nick Thatcher; Everett E Vokes; Douglas E Wood; Carol Hart
Early stage lung cancer--new approaches to evaluation and treatment: conference summary statement.
Clinical cancer research : an official journal of the American Association for Cancer Research 2005;11(13 Pt 2):4981s-4983s.
2005: James L Mulshine; Daniel C Sullivan
Clinical practice. Lung cancer screening.
The New England journal of medicine 2005;352(26):2714-20.
2005: Ingalill Avis; Alfredo Martínez; Jordi Tauler; Enrique Zudaire; Anatoly Mayburd; Raed Abu-Ghazaleh; Frank G Ondrey; James L Mulshine
Inhibitors of the arachidonic acid pathway and peroxisome proliferator-activated receptor ligands have superadditive effects on lung cancer growth inhibition.
Cancer research 2005;65(10):4181-90.
2005: James L Mulshine
New developments in lung cancer screening.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2005;23(14):3198-202.
2005: Yan-Gao Man; Ting Shen; Judith Weisz; Patricia E Berg; Arnold M Schwartz; James L Mulshine; Qing-Xiang Amy Sang; Herbert E Nieburgs
A subset of in situ breast tumor cell clusters lacks expression of proliferation and progression related markers but shows signs of stromal and vascular invasion.
Cancer detection and prevention 2005;29(4):323-31.
2005: Apar Kishor Ganti; James L Mulshine
Lung cancer screening: panacea or pipe dream?
Annals of oncology : official journal of the European Society for Medical Oncology / ESMO 2005;16 Suppl 2():ii215-9.
2005: Yan-Gao Man; Yi Zhang; Ting Shen; Xiao Zeng; Jordi Tauler; James L Mulshine; Brian L Strauss
cDNA expression profiling reveals elevated gene expression in cell clusters overlying focally disrupted myoepithelial cell layers: implications for breast tumor invasion.
Breast cancer research and treatment 2005;89(2):199-208.
2004: James L Mulshine; Len Neckers
Epithelial-directed drug delivery: influence of formulation and delivery devices.
Lung cancer (Amsterdam, Netherlands) 2004;46(3):387-92.
2004: James L Mulshine; John N Weinstein
Is the gene expression pattern of lung cancer detected by screening with spiral computed tomography different from that of symptom-detected lung cancer?
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(18 Pt 1):5973-4.
2004: Elizabeth E Warner; James L Mulshine
Lung cancer screening with spiral CT: toward a working strategy.
Oncology (Williston Park, N.Y.) 2004;18(5):564-75, discussion 578, 583-4, 587.
2004: James L Mulshine; Jane C Atkinson; Robert O Greer; Vassiliki A Papadimitrakopoulou; Carter Van Waes; Susan F Rudy; Jack W Martin; Seth M Steinberg; David J Liewehr; Ingalill Avis; R Ilona Linnoila; Stephen Hewitt; Scott M Lippman; Robin Frye; Paul F Cavanaugh
Randomized, double-blind, placebo-controlled phase IIb trial of the cyclooxygenase inhibitor ketorolac as an oral rinse in oropharyngeal leukoplakia.
Clinical cancer research : an official journal of the American Association for Cancer Research 2004;10(5):1565-73.
2003: Elizabeth E Warner; James L Mulshine
Surgical considerations with lung cancer screening.
Journal of surgical oncology 2003;84(1):1-6.
2003: James L Mulshine; Fred R Hirsch
Lung cancer chemoprevention: moving from concept to a reality.
Lung cancer (Amsterdam, Netherlands) 2003;41 Suppl 1():S163-74.
2003: Santiago Jesus Ballaz; James L Mulshine
The potential contributions of chronic inflammation to lung carcinogenesis.
Clinical lung cancer 2003;5(1):46-62.
2003: James L Mulshine
Screening for lung cancer: in pursuit of pre-metastatic disease.
Nature reviews. Cancer 2003;3(1):65-73.
2003: Mercedes Garayoa; Yan-Gao Man; Alfredo Martínez; Frank Cuttitta; James L Mulshine
Downregulation of hnRNP A2/B1 expression in tumor cells under prolonged hypoxia.
American journal of respiratory cell and molecular biology 2003;28(1):80-5.
2003: Alfredo Martínez; Teresa A Lehman; Rama Modali; James L Mulshine
Screening of mutations in the ras family of oncogenes by polymerase chain reaction-based ligase chain reaction.
Methods in molecular medicine 2003;74():187-200.
2002: James L Mulshine; Robert Smith; John Field; Fred R Hirsch
Tobacco money: up in smoke?
Lancet 2002;360(9349):1979-80; author reply 1981.
2002: Gorka Bastarrika; Jesús C Pueyo; James L Mulshine
Radiologic screening for lung cancer.
Expert review of anticancer therapy 2002;2(4):385-92.
2002: John Field; C Brambilla; N Caporaso; A Flahault; C Henschke; J Herman; F Hirsch; P Lachmann; S Lam; S Maier; L M Montuenga; James L Mulshine; M Murphy; J Pullen; M Spitz; M Tockman; R Tyndale; I Wistuba; Judith Youngson
Consensus statements from the Second International Lung Cancer Molecular Biomarkers Workshop: a European strategy for developing lung cancer molecular diagnostics in high risk populations.
International journal of oncology 2002;21(2):369-73.
2002: James L Mulshine; Frank Cuttitta; Melvyn S Tockman; LUIGI DE LUCA
Lung cancer evolution to preinvasive management.
Clinics in chest medicine 2002;23(1):37-48.
2001: James L Mulshine; S Hong; Alfredo Martínez; Jordi Tauler; Ingalill Avis; Melvyn S Tockman; LUIGI DE LUCA; ME Placke; Frank Cuttitta
Moving to the routine management of pre symptomatic lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34 Suppl 2():S1-5.
2001: J Zhou; L Nong; M Wloch; A Cantor; James L Mulshine; Melvyn S Tockman
Expression of early lung cancer detection marker: hnRNP-A2/B1 and its relation to microsatellite alteration in non-small cell lung cancer.
Lung cancer (Amsterdam, Netherlands) 2001;34(3):341-50.
2001: Ingalill Avis; SH Hong; A Martinez; Terry W Moody; Y H Choi; Jane Trepel; R Das; M Jett; James L Mulshine
Five-lipoxygenase inhibitors can mediate apoptosis in human breast cancer cell lines through complex eicosanoid interactions.
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2001;15(11):2007-9.
2001: J Zhou; D C Allred; Ingalill Avis; Alfredo Martínez; MD Vos; L Smith; AM Treston; James L Mulshine
Differential expression of the early lung cancer detection marker, heterogeneous nuclear ribonucleoprotein-A2/B1 (hnRNP-A2/B1) in normal breast and neoplastic breast cancer.
Breast cancer research and treatment 2001;66(3):217-24.
2000: James L Mulshine; LUIGI DE LUCA; Robert L Dedrick; Melvyn S Tockman; R Webster; ME Placke
Considerations in developing successful, population-based molecular screening and prevention of lung cancer.
Cancer 2000;89(11 Suppl):2465-7.
2000: Yan-Gao Man; A Martinez; I M Avis; S H Hong; Frank Cuttitta; D J Venzon; James L Mulshine
Phenotypically different cells with heterogeneous nuclear ribonucleoprotein A2/B1 overexpression show similar genetic alterations.
American journal of respiratory cell and molecular biology 2000;23(5):636-45.
2000: D L Wang; M Marko; A R Dahl; K S Engelke; ME Placke; AR Imondi; James L Mulshine; LUIGI DE LUCA
Topical delivery of 13-cis-retinoic acid by inhalation up-regulates expression of rodent lung but not liver retinoic acid receptors.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(9):3636-45.
2000: A R Dahl; I M Grossi; D P Houchens; L J Scovell; ME Placke; AR Imondi; G D Stoner; LUIGI DE LUCA; D Wang; James L Mulshine
Inhaled isotretinoin (13-cis retinoic acid) is an effective lung cancer chemopreventive agent in A/J mice at low doses: a pilot study.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(8):3015-24.
2000: SH Hong; Frank G Ondrey; I M Avis; Zhong Chen; E Loukinova; Paul F Cavanaugh; Carter Van Waes; James L Mulshine
Cyclooxygenase regulates human oropharyngeal carcinomas via the proinflammatory cytokine IL-6: a general role for inflammation?
FASEB journal : official publication of the Federation of American Societies for Experimental Biology 2000;14(11):1499-507.
2000: James L Mulshine; C I Henschke
Prospects for lung-cancer screening.
Lancet 2000;355(9204):592-3.
2000: L M Montuenga; James L Mulshine
New molecular strategies for early lung cancer detection.
Cancer investigation 2000;18(6):555-63.
1999: James L Mulshine
Reducing lung cancer risk: early detection.
Chest 1999;116(6 Suppl):493S-496S.
1999: A Chaudhry; Jorge Carrasquillo; Ingalill Avis; N Shuke; James C Reynolds; R Bartholomew; Steven M Larson; Frank Cuttitta; Bruce E Johnson; James L Mulshine
Phase I and imaging trial of a monoclonal antibody directed against gastrin-releasing peptide in patients with lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1999;5(11):3385-93.
1999: SH Hong; Ingalill Avis; MD Vos; Alfredo Martínez; AM Treston; James L Mulshine
Relationship of arachidonic acid metabolizing enzyme expression in epithelial cancer cell lines to the growth effect of selective biochemical inhibitors.
Cancer research 1999;59(9):2223-8.
1999: N Iwai; Alfredo Martínez; M J Miller; Michele Vos; James L Mulshine; AM Treston
Autocrine growth loops dependent on peptidyl alpha-amidating enzyme as targets for novel tumor cell growth inhibitors.
Lung cancer (Amsterdam, Netherlands) 1999;23(3):209-22.
1998: F M Foss; A Raubitscheck; James L Mulshine; Thomas A Fleisher; James C Reynolds; Chang H Paik; Ronald D Neumann; C Boland; P Perentesis; M R Brown; J M Frincke; C P Lollo; Steven M Larson; Jorge Carrasquillo
Phase I study of the pharmacokinetics of a radioimmunoconjugate, 90Y-T101, in patients with CD5-expressing leukemia and lymphoma.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(11):2691-700.
1998: Kenning M Anderson; Thomas M Seed; M Vos; James L Mulshine; J Meng; Waddah A Alrefai; David W Ou; Jules E Harris
5-Lipoxygenase inhibitors reduce PC-3 cell proliferation and initiate nonnecrotic cell death.
The Prostate 1998;37(3):161-73.
1998: Luis M Montuenga; J Zhou; Ingalill Avis; Michele Vos; A Martinez; Frank Cuttitta; AM Treston; Mary E Sunday; James L Mulshine
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 changes with critical stages of mammalian lung development.
American journal of respiratory cell and molecular biology 1998;19(4):554-62.
1998: J Zhou; James L Mulshine; J Y Ro; Ingalill Avis; R Yu; J J Lee; R Morice; Scott M Lippman; J S Lee
Expression of heterogeneous nuclear ribonucleoprotein A2/B1 in bronchial epithelium of chronic smokers.
Clinical cancer research : an official journal of the American Association for Cancer Research 1998;4(7):1631-40.
1997: Melvyn S Tockman; James L Mulshine; Steven Piantadosi; Yener S Erozan; P K Gupta; John Ruckdeschel; Philip R Taylor; Tatyana A Zhukov; W H Zhou; You-Lin Qiao; Shu-Xiang Yao
Prospective detection of preclinical lung cancer: results from two studies of heterogeneous nuclear ribonucleoprotein A2/B1 overexpression.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(12 Pt 1):2237-46.
1997: Michael J Kelley; R Ilona Linnoila; Ingalill Avis; M S Georgiadis; Frank Cuttitta; James L Mulshine; Bruce E Johnson
Antitumor activity of a monoclonal antibody directed against gastrin-releasing peptide in patients with small cell lung cancer.
Chest 1997;112(1):256-61.
1997: Fred R Hirsch; E Brambilla; N Gray; Ellen R Gritz; G J Kelloff; R Ilona Linnoila; U Pastorino; James L Mulshine
Prevention and early detection of lung cancer-clinical aspects.
Lung cancer (Amsterdam, Netherlands) 1997;17(1):163-74.
1997: James L Mulshine; J Zhou; AM Treston; E Szabo; Melvyn S Tockman; Frank Cuttitta
New approaches to the integrated management of early lung cancer.
Hematology/oncology clinics of North America 1997;11(2):235-52.
1997: F M Scott; Rama Modali; T A Lehman; M Seddon; K Kelly; E C Dempsey; V Wilson; Melvyn S Tockman; James L Mulshine
High frequency of K-ras codon 12 mutations in bronchoalveolar lavage fluid of patients at high risk for second primary lung cancer.
Clinical cancer research : an official journal of the American Association for Cancer Research 1997;3(3):479-82.
1996: T A Lehman; F Scott; M Seddon; K Kelly; E C Dempsey; V L Wilson; James L Mulshine; rama modali
Detection of K-ras oncogene mutations by polymerase chain reaction-based ligase chain reaction.
Analytical biochemistry 1996;239(2):153-9.
1996: F M Scott; AM Treston; G L Shaw; Ingalill Avis; J Sorenson; K Kelly; E C Dempsey; A B Cantor; M Tockman; James L Mulshine
Peptide amidating activity in human bronchoalveolar lavage fluid.
Lung cancer (Amsterdam, Netherlands) 1996;14(2-3):239-51.
1996: K A Quinn; AM Treston; Edward Joseph Unsworth; M J Miller; Michele Vos; C Grimley; J Battey; James L Mulshine; Frank Cuttitta
Insulin-like growth factor expression in human cancer cell lines.
The Journal of biological chemistry 1996;271(19):11477-83.
1996: J Zhou; James L Mulshine; Edward Joseph Unsworth; F M Scott; I M Avis; M D Vos; AM Treston
Purification and characterization of a protein that permits early detection of lung cancer. Identification of heterogeneous nuclear ribonucleoprotein-A2/B1 as the antigen for monoclonal antibody 703D4.
The Journal of biological chemistry 1996;271(18):10760-6.
1996: Bruce E Johnson; J D Bridges; M Sobczeck; J Gray; RI Linnoila; Adi F Gazdar; L Hankins; Seth M Steinberg; M Edison; J N Frame; Harvey I Pass; J Nesbitt; D Holden; James L Mulshine; E Glatstein; D C Ihde
Patients with limited-stage small-cell lung cancer treated with concurrent twice-daily chest radiotherapy and etoposide/cisplatin followed by cyclophosphamide, doxorubicin, and vincristine.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1996;14(3):806-13.
1996: J Zhou; S M Jensen; Seth M Steinberg; James L Mulshine; RI Linnoila
Expression of early lung cancer detection marker p31 in neoplastic and non-neoplastic respiratory epithelium.
Lung cancer (Amsterdam, Netherlands) 1996;14(1):85-97.
1996: I M Avis; Marti Jett; T Boyle; M D Vos; Terry W Moody; AM Treston; A Martínez; James L Mulshine
Growth control of lung cancer by interruption of 5-lipoxygenase-mediated growth factor signaling.
The Journal of clinical investigation 1996;97(3):806-13.
1996: K A Quinn; Edward Joseph Unsworth; MJ Miller; James L Mulshine; Frank Cuttitta
Biochemical characterization of mouse liver IBE1-amide immunoreactivity: limitations of antibody-based approaches for verification of peptide expression.
Peptides 1996;17(5):881-3.
1996: G L Shaw; Adi F Gazdar; R Phelps; Seth M Steinberg; RI Linnoila; Bruce E Johnson; H K Oie; E K Russell; B C Ghosh; Harvey I Pass; John D Minna; James L Mulshine; D C Ihde
Correlation of in vitro drug sensitivity testing results with response to chemotherapy and survival: comparison of non-small cell lung cancer and small cell lung cancer.
Journal of cellular biochemistry. Supplement 1996;24():173-85.
1996: M P Dearing; M J Englee-Miller; R A Kratzke; B S Kramer; Edward Chu; J Weinstein; M Anderson; D Venzon; James L Mulshine; A F Gazdar
Dipyridamole mediated enhanced antiproliferative activity of 10-ethyl-10-deazaaminopterin (10-EDAM) against human lung cancer cell lines.
Journal of cellular biochemistry. Supplement 1996;24():165-72.
1996: R M Phelps; Bruce E Johnson; D C Ihde; Adi F Gazdar; D P Carbone; P R McClintock; RI Linnoila; M J Matthews; P A Bunn; D Carney; John D Minna; James L Mulshine
NCI-Navy Medical Oncology Branch cell line data base.
Journal of cellular biochemistry. Supplement 1996;24():32-91.
1995: James L Mulshine; F Scott
Molecular markers in early cancer detection. New screening tools.
Chest 1995;107(6 Suppl):280S-286S.
1995: M J Kelley; K Nakagawa; S M Steinberg; James L Mulshine; A Kamb; Bruce E Johnson
Differential inactivation of CDKN2 and Rb protein in non-small-cell and small-cell lung cancer cell lines.
Journal of the National Cancer Institute 1995;87(10):756-61.
1995: I Avis; A Mathias; Edward Joseph Unsworth; M J Miller; F Cuttitta; James L Mulshine; Sonia B Jakowlew
Analysis of small cell lung cancer cell growth inhibition by 13-cis-retinoic acid: importance of bioavailability.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1995;6(5):485-92.
1995: James L Mulshine
Fostering chemopreventive agent development: how to proceed?
Journal of cellular biochemistry. Supplement 1995;22():254-9.
1994: D C Ihde; James L Mulshine; B S Kramer; Seth M Steinberg; RI Linnoila; Adi F Gazdar; M Edison; R M Phelps; M Lesar; J C Phares
Prospective randomized comparison of high-dose and standard-dose etoposide and cisplatin chemotherapy in patients with extensive-stage small-cell lung cancer.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1994;12(10):2022-34.
1994: E Shimizu; Angela Coxon; GA Otterson; Seth M Steinberg; Robert A Kratzke; Y W Kim; J Fedorko; H Oie; Bruce E Johnson; James L Mulshine
RB protein status and clinical correlation from 171 cell lines representing lung cancer, extrapulmonary small cell carcinoma, and mesothelioma.
Oncogene 1994;9(9):2441-8.
1994: M Ebina; Seth M Steinberg; James L Mulshine; RI Linnoila
Relationship of p53 overexpression and up-regulation of proliferating cell nuclear antigen with the clinical course of non-small cell lung cancer.
Cancer research 1994;54(9):2496-503.
1994: James L Mulshine; Bruce E Johnson; Adi F Gazdar; G L Shaw; B S Kramer; T Mitsudomi; John D Minna; Harvey I Pass; R Phelps; B Ghosh
Integrated clinical and basic studies related to circumventing non-small cell lung cancer drug resistance.
Lung cancer (Amsterdam, Netherlands) 1994;10 Suppl 1():S73-81.
1993: AM Treston; F M Scott; Michele Vos; N Iwai; R E Mains; B A Eipper; Frank Cuttitta; James L Mulshine
Biochemical characterization of peptide alpha-amidation enzyme activities of human neuroendocrine lung cancer cell lines.
Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research 1993;4(11):911-20.
1993: E Szabo; Michael J Birrer; James L Mulshine
Early detection of lung cancer.
Seminars in oncology 1993;20(4):374-82.
1993: James L Mulshine; Marti Jett; Frank Cuttitta; AM Treston; K Quinn; F Scott; N Iwai; Ingalill Avis; RI Linnoila; G L Shaw
Scientific basis for cancer prevention. Intermediate cancer markers.
Cancer 1993;72(3 Suppl):978-83.
1993: G L Shaw; James L Mulshine
Monoclonal antibodies for early cytologic detection of lung cancer.
Seminars in thoracic and cardiovascular surgery 1993;5(3):201-9.
1993: E Szabo; James L Mulshine
Epidemiology, prognostic factors, and prevention of lung cancer.
Current opinion in oncology 1993;5(2):302-9.
1993: F Scott; Frank Cuttitta; AM Treston; Ingalill Avis; P Gupta; John Ruckdeschel; K Kelly; Steven Piantadosi; M Tockman; James L Mulshine
Prospective trial evaluating immunocytochemical-based sputum techniques for early lung cancer detection: assays for promotion factors in the bronchial lavage.
Journal of cellular biochemistry. Supplement 1993;17F():175-83.
1993: James L Mulshine; AM Treston; P H Brown; Michael J Birrer; G L Shaw
Initiators and promoters of lung cancer.
Chest 1993;103(1 Suppl):4S-11S.
1993: A J Gross; Seth M Steinberg; J G Reilly; D P Bliss; J Brennan; P T Le; A Simmons; R Phelps; James L Mulshine; D C Ihde
Atrial natriuretic factor and arginine vasopressin production in tumor cell lines from patients with lung cancer and their relationship to serum sodium.
Cancer research 1993;53(1):67-74.
1993: Ingalill Avis; Marti Jett; P G Kasprzyk; Frank Cuttitta; AM Treston; R Maneckjee; James L Mulshine
Effect of gastrin-releasing peptide on the pancreatic tumor cell line (Capan).
Molecular carcinogenesis 1993;8(4):214-20.
1992: J Kim; Frederic J Kaye; J G Henslee; J E Shively; J G Park; S L Lai; R I Linnoila; James L Mulshine; Adi F Gazdar
Expression of carcinoembryonic antigen and related genes in lung and gastrointestinal cancers.
International journal of cancer. Journal international du cancer 1992;52(5):718-25.
1992: James L Mulshine
Overview: NCI Workshop on Investigational Strategies for Detection and Intervention in Early Lung Cancer.
Cancer research 1992;52(9 Suppl):2639s-2640s.
1992: James L Mulshine; N Shuke; F Daghighian; Jorge Carrasquillo; B Ghosh; T Walsh; Ingalill Avis; James C Reynolds; Frank Cuttitta; Steven M Larson
The correct dose: pharmacologically guided end point for anti-growth factor therapy.
Cancer research 1992;52(9 Suppl):2743s-2746s.
1992: RI Linnoila; S M Jensen; Seth M Steinberg; James L Mulshine; J C Eggleston; Adi F Gazdar
Peripheral airway cell marker expression in non-small cell lung carcinoma. Association with distinct clinicopathologic features.
American journal of clinical pathology 1992;97(2):233-43.
1992: James L Mulshine; RI Linnoila; AM Treston; F M Scott; K Quinn; Ingalill Avis; G L Shaw; S M Jensen; P Brown; Michael J Birrer
Candidate biomarkers for application as intermediate end points of lung carcinogenesis.
Journal of cellular biochemistry. Supplement 1992;16G():183-6.
1992: James L Mulshine; Michael J Birrer; AM Treston; F Scott; K Quinn; Ingalill Avis; Frank Cuttitta
Growth factors and other targets for rational application as intervention agents.
Advances in experimental medicine and biology 1992;320():81-8.
1992: James L Mulshine; RI Linnoila; S M Jensen; J L Magnani; M S Tockman; P K Gupta; F S Scott; Ingalill Avis; K Quinn; Michael J Birrer
Rational targets for the early detection of lung cancer.
Journal of the National Cancer Institute. Monographs 1992;(13):183-90.
1992: AM Treston; James L Mulshine; Frank Cuttitta
Control of tumor cell biology through regulation of peptide hormone processing.
Journal of the National Cancer Institute. Monographs 1992;(13):169-75.
1992: RI Linnoila; James L Mulshine; Seth M Steinberg; Adi F Gazdar
Expression of surfactant-associated protein in non-small-cell lung cancer: a discriminant between biologic subsets.
Journal of the National Cancer Institute. Monographs 1992;(13):61-6.
1992: Adi F Gazdar; C Kadoyama; D Venzon; J G Park; C M Tsai; RI Linnoila; James L Mulshine; D C Ihde; G Giaccone
Association between histological type and neuroendocrine differentiation on drug sensitivity of lung cancer cell lines.
Journal of the National Cancer Institute. Monographs 1992;(13):191-6.
1992: T Mitsudomi; Seth M Steinberg; Marion M Nau; D Carbone; D D'Amico; S Bodner; H K Oie; RI Linnoila; James L Mulshine; John D Minna
p53 gene mutations in non-small-cell lung cancer cell lines and their correlation with the presence of ras mutations and clinical features.
Oncogene 1992;7(1):171-80.
1991: K A Quinn; AM Treston; F M Scott; P G Kasprzyk; Ingalill Avis; J M Siegfried; James L Mulshine; Frank Cuttitta
Alpha-amidation of peptide hormones in lung cancer.
Cancer cells (Cold Spring Harbor, N.Y. : 1989) 1991;3(12):504-10.
1991: Ingalill Avis; T O Kovacs; P G Kasprzyk; AM Treston; R Bartholomew; J H Walsh; Frank Cuttitta; James L Mulshine
Preclinical evaluation of an anti-autocrine growth factor monoclonal antibody for treatment of patients with small-cell lung cancer.
Journal of the National Cancer Institute 1991;83(20):1470-6.
1991: T Mitsudomi; Seth M Steinberg; H K Oie; James L Mulshine; R Phelps; J Viallet; Harvey I Pass; John D Minna; Adi F Gazdar
ras gene mutations in non-small cell lung cancers are associated with shortened survival irrespective of treatment intent.
Cancer research 1991;51(18):4999-5002.
1991: T Mitsudomi; J Viallet; James L Mulshine; RI Linnoila; John D Minna; Adi F Gazdar
Mutations of ras genes distinguish a subset of non-small-cell lung cancer cell lines from small-cell lung cancer cell lines.
Oncogene 1991;6(8):1353-62.
1991: James L Mulshine; AM Treston; F M Scott; Ingalill Avis; C Boland; R Phelps; P G Kasprzyk; Y Nakanishi; Frank Cuttitta
Lung cancer: rational strategies for early detection and intervention.
Oncology (Williston Park, N.Y.) 1991;5(5):25-32; discussion 32-3, 37.
1991: James L Mulshine; Jorge Carrasquillo; John N Weinstein; A M Keenan; James C Reynolds; J Herdt; P A Bunn; Edward A Sausville; J Eddy; J D Cotelingam
Direct intralymphatic injection of radiolabeled 111In-T101 in patients with cutaneous T-cell lymphoma.
Cancer research 1991;51(2):688-95.
1990: R M Phelps; M P Dearing; James L Mulshine
Need for uniformity in collection and reporting of data in cancer clinical trials.
Journal of the National Cancer Institute 1990;82(17):1377-8.
1990: Adi F Gazdar; RI Linnoila; Y Kurita; H K Oie; James L Mulshine; J C Clark; J A Whitsett
Peripheral airway cell differentiation in human lung cancer cell lines.
Cancer research 1990;50(17):5481-7.
1990: Ethan Dmitrovsky; E J Seifter; Adi F Gazdar; C M Tsai; M Edison; P Brantley; S R Veach; G Batist; D C Ihde; James L Mulshine
A phase II trial of carboplatin (CBDCA) in small-cell and non-small-cell lung cancer with correlation to in vitro analysis of cytotoxicity.
American journal of clinical oncology 1990;13(4):285-9.
1990: M P Dearing; Seth M Steinberg; R Phelps; M J Anderson; James L Mulshine; D C Ihde; Bruce E Johnson
Outcome of patients with small-cell lung cancer: effect of changes in staging procedures and imaging technology on prognostic factors over 14 years.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology 1990;8(6):1042-9.
1989: S L Lai; L J Goldstein; Michael M Gottesman; Ira Pastan; C M Tsai; Bruce E Johnson; James L Mulshine; D C Ihde; K Kayser; Adi F Gazdar
MDR1 gene expression in lung cancer.
Journal of the National Cancer Institute 1989;81(15):1144-50.
1989: James L Mulshine; AM Treston; R B Natale; P G Kasprzyk; Ingalill Avis; Y Nakanishi; Frank Cuttitta
Autocrine growth factors as therapeutic targets in lung cancer.
Chest 1989;96(1 Suppl):31S-34S.
1989: James L Mulshine; M S Tockman; C R Smart
Considerations in the development of lung cancer screening tools.
Journal of the National Cancer Institute 1989;81(12):900-6.
1989: C M Tsai; Adi F Gazdar; D J Venzon; Seth M Steinberg; Robert L Dedrick; James L Mulshine; B S Kramer
Lack of in vitro synergy between etoposide and cis-diamminedichloroplatinum(II).
Cancer research 1989;49(9):2390-7.
1989: James L Mulshine; Ingalill Avis; AM Treston; P G Kaspryzyk; Y Nakanishi; C Mobley; Jorge Carrasquillo; Steven M Larson; B Merchant; Frank Cuttitta
In vivo diagnosis and therapy of human tumors with monoclonal antibodies: selection of antibodies and preliminary clinical studies in small cell carcinoma of the lung.
International journal of radiation applications and instrumentation. Part B, Nuclear medicine and biology 1989;16(2):159-62.
1988: RI Linnoila; James L Mulshine; Seth M Steinberg; K Funa; M J Matthews; J D Cotelingam; Adi F Gazdar
Neuroendocrine differentiation in endocrine and nonendocrine lung carcinomas.
American journal of clinical pathology 1988;90(6):641-52.
1988: Jane Trepel; J D Moyer; F Cuttitta; H Frucht; D H Coy; R B Natale; James L Mulshine; R T Jensen; Edward A Sausville
A novel bombesin receptor antagonist inhibits autocrine signals in a small cell lung carcinoma cell line.
Biochemical and biophysical research communications 1988;156(3):1383-9.
1988: P G Kasprzyk; Frank Cuttitta; Ingalill Avis; Y Nakanishi; AM Treston; H Wong; J H Walsh; James L Mulshine
Solid-phase peptide quantitation assay using labeled monoclonal antibody and glutaraldehyde fixation.
Analytical biochemistry 1988;174(1):224-34.
1988: Adi F Gazdar; Lee Helman; Mark Israel; E K Russell; RI Linnoila; James L Mulshine; H M Schuller; J G Park
Expression of neuroendocrine cell markers L-dopa decarboxylase, chromogranin A, and dense core granules in human tumors of endocrine and nonendocrine origin.
Cancer research 1988;48(14):4078-82.
1988: Y Nakanishi; James L Mulshine; P G Kasprzyk; R B Natale; R Maneckjee; Ingalill Avis; AM Treston; Adi F Gazdar; John D Minna; Frank Cuttitta
Insulin-like growth factor-I can mediate autocrine proliferation of human small cell lung cancer cell lines in vitro.
The Journal of clinical investigation 1988;82(1):354-9.
1988: P G Kasprzyk; Frank Cuttitta; AM Treston; Ingalill Avis; Y Nakanishi; H Wong; J H Walsh; James L Mulshine
Consideration of the chemistry of solid-phase matrix interaction leads to improved quantitation of neuropeptides.
Annals of the New York Academy of Sciences 1988;547():41-53.
1988: James L Mulshine; Ingalill Avis; AM Treston; C Mobley; P Kaspryzyk; Jorge Carrasquillo; Steven M Larson; Y Nakanishi; B Merchant; John D Minna
Clinical use of a monoclonal antibody to bombesin-like peptide in patients with lung cancer.
Annals of the New York Academy of Sciences 1988;547():360-72.
1988: Y Nakanishi; Frank Cuttitta; P G Kasprzyk; Ingalill Avis; S M Steinberg; Adi F Gazdar; James L Mulshine
Growth factor effects on small cell lung cancer cells using a colorimetric assay: can a transferrin-like factor mediate autocrine growth?
Experimental cell biology 1988;56(1-2):74-85.
1987: James L Mulshine; A M Keenan; Jorge Carrasquillo; T Walsh; R I Linnoila; O D Holton; J Harwell; Steven M Larson; P A Bunn; John N Weinstein
Immunolymphoscintigraphy of pulmonary and mediastinal lymph nodes in dogs: a new approach to lung cancer imaging.
Cancer research 1987;47(13):3572-6.
1987: John N Weinstein; R R Eger; D G Covell; C D Black; James L Mulshine; Jorge Carrasquillo; Steven M Larson; A M Keenan
The pharmacology of monoclonal antibodies.
Annals of the New York Academy of Sciences 1987;507():199-210.
1985: Frank Cuttitta; D N Carney; James L Mulshine; Terry W Moody; J Fedorko; A Fischler; John D Minna
Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
Nature 1985;316(6031):823-6.
1985: Frank Cuttitta; D N Carney; James L Mulshine; Terry W Moody; J Fedorko; A Fischler; John D Minna
Autocrine growth factors in human small cell lung cancer.
Cancer surveys 1985;4(4):707-27.